BerGenBio ASA (BRRGF)
USD 2.31
(-7.6%)
USD 2.31
(-7.6%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -191.81 Million NOK | 38.62% |
| 2022 | -32.22 Million USD | 13.2% |
| 2021 | -37.12 Million USD | -19.53% |
| 2020 | -31.05 Million USD | -21.23% |
| 2019 | -25.61 Million USD | -3.95% |
| 2018 | -24.64 Million USD | -9.3% |
| 2017 | -22.54 Million USD | -40.52% |
| 2016 | -16.04 Million USD | -94.89% |
| 2015 | -8.23 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.77 Million USD | 6.14% |
| 2024 Q2 | -4.85 Million USD | -24.2% |
| 2023 Q1 | -7.02 Million USD | 15.69% |
| 2023 Q3 | -2.73 Million USD | 40.12% |
| 2023 Q4 | -4.83 Million USD | -76.63% |
| 2023 Q2 | -4.56 Million USD | 34.98% |
| 2023 FY | -19.77 Million USD | 38.62% |
| 2022 Q2 | -9.04 Million USD | 0.4% |
| 2022 FY | -32.22 Million USD | 13.2% |
| 2022 Q4 | -8.33 Million USD | -42.49% |
| 2022 Q3 | -5.84 Million USD | 35.34% |
| 2022 Q1 | -9.07 Million USD | -3.78% |
| 2021 Q2 | -10.79 Million USD | -9.7% |
| 2021 FY | -37.12 Million USD | -19.53% |
| 2021 Q1 | -9.83 Million USD | 0.0% |
| 2021 Q4 | -8.74 Million USD | -5.12% |
| 2021 Q3 | -8.32 Million USD | 22.89% |
| 2020 FY | -31.05 Million USD | -21.23% |
| 2019 FY | -25.61 Million USD | -3.95% |
| 2018 FY | -24.64 Million USD | -9.3% |
| 2017 FY | -22.54 Million USD | -40.52% |
| 2016 FY | -16.04 Million USD | -94.89% |
| 2015 FY | -8.23 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | -17.84 Million USD | -974.797% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -3702.55% |
| CSL Limited | 3.7 Billion USD | 105.181% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 334.349% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -27823.284% |
| BioStem Technologies, Inc. | -7.77 Million USD | -2365.867% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -15172.213% |
| Qrons Inc. | -643.67 Thousand USD | -29700.506% |
| Nascent Biotech, Inc. | -2.22 Million USD | -8502.216% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -245.57% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -2785.358% |
| Skye Bioscience, Inc. | -13.67 Million USD | -1303.027% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -46068.158% |
| Rebus Holdings, Inc. | -664 Thousand USD | -28788.404% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -1108.709% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -14263.827% |
| Genscript Biotech Corporation | -415.79 Million USD | 53.866% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -49138.648% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -167.209% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 4002.876% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -73190.006% |
| SQZ Biotechnologies Company | -75.82 Million USD | -152.976% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -6629.294% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -12387.818% |
| Mesoblast Limited | -84.14 Million USD | -127.957% |
| Marizyme, Inc. | -34.08 Million USD | -462.742% |
| Genus plc | 6.4 Million USD | 3097.172% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 2068.897% |
| Pharming Group N.V. | -4.87 Million USD | -3831.085% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -9556.231% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -20495.138% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -2197.234% |
| ContraFect Corporation | -56.88 Million USD | -237.181% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -4111.428% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -13581.9% |
| IMV Inc. | -38.67 Million USD | -396.021% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -6873.109% |
| MultiCell Technologies, Inc. | -722.81 USD | -26537856.033% |
| ONE Bio Corp. | 13.68 Million USD | 1502.027% |
| Accustem Sciences Inc. | -3.74 Million USD | -5020.063% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -225.172% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -39608.981% |
| Q BioMed Inc. | -3.44 Million USD | -5467.045% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 5518.616% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -7200.377% |
| Biomind Labs Inc. | -1 Million USD | -18899.448% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -248.937% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -6511.598% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -10188.677% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -640321.341% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -9825.386% |
| GB Sciences, Inc. | -1.42 Million USD | -13403.54% |
| Alpha Cognition Inc. | -9.7 Million USD | -1876.374% |
| HST Global, Inc. | -140.9 Thousand USD | -136031.633% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -16952.003% |
| Halberd Corporation | -75.05 Thousand USD | -255488.274% |
| Enzolytics Inc. | -2.14 Million USD | -8826.796% |
| Agentix Corp. | -1.37 Million USD | -13883.464% |
| Resverlogix Corp. | -12.74 Million USD | -1404.581% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -5954.369% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 54.871% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -18273.467% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -6470.395% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -12045.401% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -5533.486% |
| AVAX Technologies, Inc. | 6.69 Million USD | 2966.016% |
| Zenith Capital Corp. | -8.94 Million USD | -2044.907% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -1100979.157% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -7712.392% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -111741.592% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -9468.192% |
| Kadimastem Ltd | -3.04 Million USD | -6209.317% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -19392.751% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -105594.135% |
| LadRx Corporation | -3.82 Million USD | -4916.678% |
| Cell Source, Inc. | -4.32 Million USD | -4334.767% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -27823.284% |
| NovAccess Global Inc. | -2.46 Million USD | -7676.152% |
| Affymax, Inc. | -15.04 Million USD | -1174.884% |
| Itoco Inc. | -919.14 Thousand USD | -20769.4% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -4425.726% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -17042.002% |
| Mobile Lads Corp. | -554.55 Thousand USD | -34490.028% |
| CytoDyn Inc. | -18.05 Million USD | -962.238% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -761993.762% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -87059.553% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -33866.918% |
| SYBLEU INC | -149.18 Thousand USD | -128482.25% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -10460.859% |
| International Stem Cell Corporation | -663 Thousand USD | -28831.976% |
| Bioxytran, Inc. | -3.82 Million USD | -4921.247% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -364297.796% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -942962.93% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -428.922% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -11755.315% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -25968.208% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -6065.831% |
| Neutra Corp. | -229.48 Thousand USD | -83486.363% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -993.671% |
| PureTech Health plc | -146.19 Million USD | -31.204% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -792.55% |
| IXICO plc | -1.43 Million USD | -13248.573% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -1921.062% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -57.479% |
| CSL Limited | 3.81 Billion USD | 105.032% |
| Cellectis S.A. | -108.85 Million USD | -76.211% |